Total Payments
$203,756
2024 Payments
$75,052
Companies
34
Transactions
642
Medicare Patients
20,495
Medicare Billing
$2.2M
Payment Breakdown by Category
Other$109,185 (53.6%)
Consulting$54,675 (26.8%)
Food & Beverage$24,430 (12.0%)
Travel$15,332 (7.5%)
Education$134.19 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $83,910 | 32 | 41.2% |
| Consulting Fee | $54,675 | 19 | 26.8% |
| Food and Beverage | $24,430 | 508 | 12.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $23,175 | 10 | 11.4% |
| Travel and Lodging | $15,332 | 69 | 7.5% |
| Honoraria | $2,100 | 2 | 1.0% |
| Education | $134.19 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $40,790 | 117 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $33,746 | 68 | $0 (2024) |
| Glaukos Corporation | $31,321 | 35 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $28,344 | 63 | $0 (2021) |
| Alcon Vision LLC | $18,225 | 82 | $0 (2024) |
| Nova Eye, Inc. | $16,986 | 5 | $0 (2024) |
| Allergan, Inc. | $9,677 | 87 | $0 (2022) |
| Sight Sciences, Inc. | $8,827 | 24 | $0 (2024) |
| Alcon Research LLC | $4,179 | 3 | $0 (2024) |
| NEW WORLD MEDICAL,INC. | $3,792 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75,052 | 155 | Glaukos Corporation ($28,761) |
| 2023 | $52,753 | 160 | ABBVIE INC. ($26,771) |
| 2022 | $31,654 | 99 | Nova Eye, Inc. ($9,876) |
| 2021 | $16,756 | 76 | Aerie Pharmaceuticals, Inc. ($6,958) |
| 2020 | $14,036 | 69 | Aerie Pharmaceuticals, Inc. ($10,785) |
| 2019 | $11,434 | 66 | Aerie Pharmaceuticals, Inc. ($10,567) |
| 2018 | $287.45 | 7 | Alcon Laboratories Inc ($171.77) |
| 2017 | $1,784 | 10 | Alcon Laboratories Inc ($1,303) |
All Payment Transactions
642 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | NEW WORLD MEDICAL,INC. | Kahook Dual Blade (Device), Clearpath, Ahmed Glaucoma Valve | Honoraria | Cash or cash equivalent | $600.00 | General |
| Category: Ophthalmology | ||||||
| 12/17/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,625.00 | General |
| Category: EYE CARE | ||||||
| 12/13/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: EYE CARE | ||||||
| 12/11/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $51.86 | General |
| Category: EYE CARE | ||||||
| 12/11/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Travel and Lodging | In-kind items and services | $33.50 | General |
| Category: EYE CARE | ||||||
| 12/09/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/06/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $2.15 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/04/2024 | Glaukos Corporation | iDose (Device) | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| Category: Glaucoma | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Glaukos Corporation | — | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| 12/04/2024 | Glaukos Corporation | — | Travel and Lodging | Cash or cash equivalent | $354.71 | General |
| 12/04/2024 | Glaukos Corporation | iDose (Device) | Travel and Lodging | Cash or cash equivalent | $73.70 | General |
| Category: Glaucoma | ||||||
| 12/04/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: EYE CARE | ||||||
| 12/02/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Travel and Lodging | In-kind items and services | $312.35 | General |
| Category: EYE CARE | ||||||
| 12/02/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: EYE CARE | ||||||
| 12/02/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: EYE CARE | ||||||
| 11/26/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,267.79 | General |
| Category: Ophthalmology | ||||||
| 11/22/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: EYE CARE | ||||||
| 11/21/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/20/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: EYE CARE | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $197.96 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: Ophthalmology | ||||||
| 11/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 6,095 | 7,389 | $2.9M | $608,282 |
| 2022 | 28 | 5,829 | 6,942 | $2.7M | $598,733 |
| 2021 | 24 | 4,928 | 6,205 | $2.7M | $569,306 |
| 2020 | 25 | 3,643 | 4,847 | $1.9M | $440,182 |
Total Patients
20,495
Total Services
25,383
Medicare Billing
$2.2M
Procedure Codes
106
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,152 | 1,742 | $348,400 | $170,938 | 49.1% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 60 | 93 | $353,400 | $39,252 | 11.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 620 | 714 | $142,800 | $37,282 | 26.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 329 | 490 | $85,800 | $35,117 | 40.9% |
| 66183 | Insertion of eye fluid drainage device | Facility | 2023 | 30 | 37 | $140,600 | $32,819 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 253 | 253 | $75,900 | $32,263 | 42.5% |
| 66991 | Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | Facility | 2023 | 38 | 52 | $197,600 | $30,628 | 15.5% |
| 92133 | Imaging of optic nerve | Office | 2023 | 825 | 953 | $285,900 | $27,504 | 9.6% |
| 66174 | Dilation of fluid outflow drainage within eye | Facility | 2023 | 56 | 80 | $384,000 | $24,989 | 6.5% |
| 65778 | Placement of amniotic membrane on eye surface for wound healing | Office | 2023 | 13 | 20 | $74,000 | $24,742 | 33.4% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 925 | 955 | $71,625 | $21,492 | 30.0% |
| 92250 | Photography of the retina | Office | 2023 | 664 | 691 | $86,375 | $21,091 | 24.4% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 47 | 65 | $143,000 | $13,519 | 9.5% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 15 | 20 | $80,000 | $10,907 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 148 | $18,500 | $10,891 | 58.9% |
| 66761 | Creation of eye fluid drainage tracts in iris using a laser, per session | Office | 2023 | 22 | 40 | $88,000 | $10,512 | 11.9% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 29 | 35 | $79,200 | $10,010 | 12.6% |
| 66989 | Complex extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | Facility | 2023 | 11 | 13 | $52,000 | $9,541 | 18.3% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 199 | 252 | $63,000 | $9,039 | 14.3% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 83 | 85 | $19,250 | $8,661 | 45.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 72 | 72 | $25,200 | $8,600 | 34.1% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 23 | 36 | $20,150 | $6,242 | 31.0% |
| 92134 | Imaging of retina | Office | 2023 | 117 | 131 | $39,300 | $4,361 | 11.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $5,250 | $2,744 | 52.3% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 236 | 236 | $25,960 | $2,068 | 8.0% |
About Dr. Billy Pan, MD
Dr. Billy Pan, MD is a Glaucoma Specialist healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2013. The National Provider Identifier (NPI) number assigned to this provider is 1760828248.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Billy Pan, MD has received a total of $203,756 in payments from pharmaceutical and medical device companies, with $75,052 received in 2024. These payments were reported across 642 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($83,910).
As a Medicare-enrolled provider, Pan has provided services to 20,495 Medicare beneficiaries, totaling 25,383 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Ad
Practice Information
- Specialty Glaucoma Specialist
- Location Beverly Hills, CA
- Active Since 05/10/2013
- Last Updated 05/06/2020
- Taxonomy Code 207WX0009X
- Entity Type Individual
- NPI Number 1760828248
Products in Payments
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $46,860
- VYZULTA (Drug) $32,015
- Rhopressa (Drug) $10,601
- rhopressa (Drug) $9,935
- Clareon (Device) $8,753
- rocklatan (Drug) $8,016
- OMNI SURGICAL SYSTEM (Device) $7,870
- iDose (Device) $7,292
- HYDRUS Microstent (Device) $6,857
- Kahook Dual Blade (Device) $3,045
- Hydrus Microstent (Device) $1,636
- Hydrus (Device) $1,022
- LUMIGAN (Drug) $895.83
- DURYSTA (Drug) $847.62
- OMNI(R) SURGICAL SYSTEM (US) (Device) $770.59
- XIIDRA (Drug) $556.19
- XEN (Device) $477.44
- AcrySof IQ PanOptix (Device) $417.43
- LOTEMAX SM (Drug) $390.37
- VUITY (Drug) $384.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.